Morbidity

Percent prevalence of chronic conditions among users of chronic drugs program, 2016*

Chronic conditions	Prevalence
Cardiovascular diseases, atherosclerosis, coagulation problems and hypertension	47%
Diabetes	15%
Ulcers	10%
High cholesterol level	10%
Other diseases (Rheumatism, uric acid, glaucoma, osteoporosis...)	8%
Diseases of the nervous system	3%
Epilepsy	3%
Thyroid Problems	2%
Asthma	2%

*For previous years check the Statistical Bulletins' page

Newly reported HIV cases, 2020

Newly reported HIV cases,2021

Newly reported HIV cases, 2022

New reported HIV cases,2023

New reported HIV cases,2024

https://www.moph.gov.lb/userfiles/files/Prevention/TB%20Program/NTP-NAP%20Annual%20Report-2024.pdf

Number of Measles cases

	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
Measles	9	1,760	235	39	44	126	952	1070	-	28	95	351

Source :MoPH 01/09/2024

Number of Tuberculosis cases*

Tuberculosis cases	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total number of cases	630	689	682	666	657	632	668	760	656	466	510	510	540
Number of Lebanese cases	330	341	337	312	305	271	254	288	277	233	263	249	225
Number of Non-Lebanese cases	300	348	345	354	352	361	414	472	379	233	247	261	315

*MOPH National Tuberculosis Program 01/05/2025

The trend in Tuberculosis cases by Nationality between 2019 and 2024

All

ATC	Name	B/G	Ingredients	Dosage	Form	Price
C09AA05	NORMOPRIL	G	Ramipril - 10mg	10mg	Tablet	599,354 L.L
J05AG01	NEPINE	G	Nevirapine - 200mg	200mg	Tablet	5,921,678 L.L
R01AD09	NASONEX	B	Mometasone furoate (monohydrate) - 50mcg/dose	0.05%	Spray, suspension	529,474 L.L
R01AD11	NASACORT AQ	B	Triamcinolone acetonide - 55mcg/dose	55mcg/dose	Spray, suspension	1,003,850 L.L
R01AD11	NASACORT AQ	B	Triamcinolone acetonide - 55mcg/dose	55mcg/dose	Spray, suspension	1,003,850 L.L
R01AB06	NARIX	G	Xylometazoline HCl - 90mcg/actuation, Carbocisteine - 900mcg/actuation		Spray	518,339 L.L
H01BA02	NICTUR	G	Desmopressin acetate - 360mcg/ml	360mcg/ml	Solution	5,270,550 L.L
C08CA05	NIFE-PAR	G	Nifedipine - 5mg/ml	5mg/ml	Solution	38,120,008 L.L
A04AA01	NAUSETRON	G	Ondansetron - 4mg/5ml	4mg/5ml	Solution	958,608 L.L
A04AA01	NAUSETRON	G	Ondansetron - 4mg/5ml	4mg/5ml	Solution	802,466 L.L
G02BA	NUVARING	B	Etonogestrel - 0.12mg/day, Ethinylestradiol - 0.015mg/day		Ring	1,052,229 L.L
D06BA05	NEO SULFA	G	Sulfanilamide - 12g	12g	Powder	151,022 L.L
N04BC09	NEUPRO	B	Rotigotine - 2mg/24h	2mg/24h	Patch	4,427,961 L.L
N04BC09	NEUPRO	B	Rotigotine - 4mg/24h	4mg/24h	Patch	7,292,823 L.L
N04BC09	NEUPRO	B	Rotigotine - 6mg/24h	6mg/24h	Patch	9,427,593 L.L
N04BC09	NEUPRO	B	Rotigotine - 8mg/24h	8mg/24h	Patch	12,394,936 L.L
C01DA02	NITRODERM TTS 5	B	Glyceryl trinitrate - 5mg/24h	5mg/24h	Patch	683,159 L.L
S01AA23	NETTACIN	B	Netilmicin - 0.3%	0.3%	Ointment	593,978 L.L
A10AD05	NOVOMIX 30	BioTech	Insulin aspart - 30%, Insulin aspart protamine - 70%	100IU/ml	Injectable suspension	4,264,012 L.L
A10AD05	NOVOMIX 30	BioTech	Insulin aspart - 30%, Insulin aspart protamine - 70%	100IU/ml	Injectable suspension	4,264,012 L.L
A10AD05	NOVOMIX 30	BioTech	Insulin aspart - 30%, Insulin aspart protamine - 70%	100IU/ml	Injectable suspension	4,264,012 L.L
L03AA02	NEOGRASTIM 30	BioTech	Filgrastim - 300mcg/ml	300mcg/ml	Injectable solution	1,970,969 L.L
L03AA02	NEUTROMAX	BioTech	Filgrastim - 300mcg/ml	300mcg/ml	Injectable solution	2,553,301 L.L
L03AA02	NEUPOGEN	BioTech	Filgrastim - 300mcg/0.5ml	300mcg/0.5ml	Injectable solution	5,250,393 L.L
L03AA02	NIVESTIM	BioTech	Filgrastim - 30MIU/0.5ml	30MIU/0.5ml	Injectable solution	17,110,745 L.L
L03AA13	NEULASTIM	BioTech	Pegfilgrastim - 6mg/0.6ml	6mg/0.6ml	Injectable solution	56,925,965 L.L
N02AF02	NALBUPHINE RENAUDIN 1%	G	Nalbuphine HCl - 20mg/2ml	20mg/2ml	Injectable solution	1,181,238 L.L
A10AB05	NOVORAPID FLEXPEN	BioTech	Insulin aspart - 100IU/ml	100IU/ml	Injectable solution	3,123,090 L.L
A10AB05	NOVORAPID FLEXPEN	BioTech	Insulin aspart - 100IU/ml	100IU/ml	Injectable solution	3,123,090 L.L
A10AB05	NOVORAPID FLEXPEN	BioTech	Insulin aspart - 100IU/ml	100IU/ml	Injectable solution	3,123,090 L.L